Selective Estrogen Receptor Modulators (SERMs) - A Potential New Treatment for women of child-bearing age with Psychotic Symptoms of Schizophrenia [ 2011 - 2013 ]

Research Grant

Researchers: Prof Jayashri Kulkarni (Principal investigator) ,  Dr Caroline Gurvich ,  Prof Susan Davis

Brief description Schizophrenia is a devastating illness urgently requiring a new treatment approach. We have discovered that estrogen is an effective treatment for women with schizophrenia and are currently trialling a safer Selective Estrogen Receptor Modulator (SERM) known as brain estrogen� in postmenopausal women with schizophrenia. Regulatory permission is now available to trial the SERM in younger women, and we seek to extend our current SERM study into child bearing age women with schizophrenia.

Funding Amount $AUD 210,480.28

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant